Practice-Changing Results for Metastatic Prostate CancerPractice-Changing Results for Metastatic Prostate Cancer

For patients with metastatic hormone-sensitive prostate cancer, upfront chemotherapy with docetaxel, given at the same time as hormone therapy, prolongs survival, new research shows. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news